Medico-economic Evaluation Comparing Intensity-Modulated Radiation Therapy (IMRT) Performed by Helical Tomotherapy and Dynamic Arc Therapy in Prostate, Cervical and Anal Canal Cancers
Conditions
Prostate Cancer - Cervical Cancer - Anal Canal Cancers
Conditions: official terms
Anus Neoplasms - Uterine Cervical Neoplasms
Conditions: Keywords
prostate, cervical and anal canal cancers with pelvic lymph node irradiation
Study Type
Interventional
Study Phase
N/A
Study Design
Intervention Model: Single Group Assignment, Masking: Open Label
Intervention
Name: Intensity-Modulated Radiation Therapy
Type: Radiation
Overall Status
Recruiting
Summary
The aim of the study is a medico-economic evaluation to estimate a cost differential between three modalities of Intensity-Modulated Radiation Therapy for cancers of the prostate, cervix and anal canal with pelvic lymph node irradiation : treatment with helical Tomotherapy and dynamic arc therapy using two different technologies: RapidArc or VMAT.
Criteria for eligibility
Healthy Volunteers: No
Maximum Age: N/A
Minimum Age: 18 Years
Gender: Both
Criteria: Inclusion Criteria:

- WHO performance index ≤ 2

- Age > 18 years

- histologically proven carcinoma: Anal canal cancer locally advanced (> 4 cm and / or N1 to N3) under irradiation on pelvic and inguinal lymph nodes with concurrent chemotherapy. The boost with brachytherapy are accepted Prostate cancer with pelvic lymph nodes and radiation or hormone therapy Cervical Cancer under a purely medical treatment involving irradiation on pelvic lymph nodes and primary tumor with concurrent chemotherapy without surgery. The Boost by external radiotherapy or brachytherapy are accepted.

- The investigator must ensure that the patient has not expressed its opposition to participate in this study. The signing of a consent form is optional;

Exclusion Criteria:

- History of invasive cancer other than basal cell carcinomas.

- Indication of re-irradiation

- para-aortic radiotherapy associated with pelvic irradiation.

- post-operative radiotherapy.

- geographical distance
Locations
Institut Sainte Catherine
Avignon, France
Status: Not yet recruiting
Contact: Nicolas Pourel, MD
Institut Bergonié
Bordeaux, France
Status: Not yet recruiting
Contact: Guy Kantor, MD
Centre Léon Bérard
Lyon, France
Status: Not yet recruiting
Contact: Pascal Pommier, MD
Assistance publique des Hôpitaux de Marseille
Marseille, France
Status: Not yet recruiting
Contact: Didier Cowen, MD
Institut Paoli Calmette
Marseille, France
Status: Not yet recruiting
Contact: Michel Resbeut, MD
Hôpital Clinique Claude Bernard
Metz, France
Status: Not yet recruiting
Contact: Guillaume Faure, MD
Groupe Oncorad
Montauban, France
Status: Not yet recruiting
Contact: Philippe Dudouet, MD
Centre Val d'Aurelle
Montpellier, France
Status: Not yet recruiting
Contact: David Azria, MD
Centre Alexis Vautrin
Nancy, France
Status: Not yet recruiting
Contact: Didier Peiffert, MD
Hôpital Européen Georges Pompidou
Paris, France
Status: Not yet recruiting
Contact: Philippe Giraud, MD
Institut Curie
Paris, France
Status: Not yet recruiting
Contact: Campitelli, MD
Centre René Gauducheau
Saint Herblain, France
Status: Recruiting
Contact: Marc-André Mahé - ma-mahe@nantes.fnclcc.fr
Centre Paul Strauss
Strasbourg, France
Status: Not yet recruiting
Contact: Georges Noel, MD
Groupe Oncorad
Toulouse, France
Status: Not yet recruiting
Contact: Denis Franck, MD
Institut Claudius Regaud
Toulouse, France
Status: Not yet recruiting
Contact: Jean-Marc Bachaud, MD
Start Date
March 2011
Sponsors
Centre René Gauducheau
Source
Centre René Gauducheau
Record processing date
ClinicalTrials.gov processed this data on July 28, 2015
ClinicalTrials.gov page